Gubelin Harcha W, Barboza Martnez J, Tsai TF, Katsuoka K, Kawashima M, Tsuboi R, et al
heart failure risk - An FDA warning (4/6/16) was added to saxagliptin regarding an increased risk of heart failure observed in two randomized trials (3.5% risk vs 2.8% for those taking placebo)
The Research-Integrity Context Dihexa's safety picture cannot be separated from the state of its evidence base
Chronic inflammation is a major contributor to joint pain and discomfort (Sikora et al., 2021)
Its important to note that while price is a factor to consider, its equally essential to choose high-quality and reputable brands to ensure safety and effectiveness
Stejerean-Todoran I, Gibhardt CS, Bogeski I